Breast-话题@MedSci

#Breast#

73篇内容 | 2554人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1351122, encodeId=6c571351122d1, content=<a href='/topic/show?id=12e43e1263' target=_blank style='color:#2F92EE;'>#Breast#</a>, objectTitle=ESMO 2022：T-DXd治疗乳腺癌不仅能提高生存，还能改善生活质量（DESTINY-Breast04研究）, objectType=article, longId=739078, objectId=084fe3907869, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=084fe3907869, replyNumber=0, likeNumber=98, createdTime=2022-09-13, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=084fe3907869, moduleTitle=ESMO 2022：T-DXd治疗乳腺癌不仅能提高生存，还能改善生活质量（DESTINY-Breast04研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=084fe3907869)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1351121, encodeId=cfc5135112171, content=<a href='/topic/show?id=12e43e1263' target=_blank style='color:#2F92EE;'>#Breast#</a>, objectTitle=Breast Cancer Res Treat：局部亚微米颗粒紫杉醇可有效治疗乳腺癌皮肤转移, objectType=article, longId=732190, objectId=8672e321901f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8672e321901f, replyNumber=0, likeNumber=110, createdTime=2022-07-13, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8672e321901f, moduleTitle=Breast Cancer Res Treat：局部亚微米颗粒紫杉醇可有效治疗乳腺癌皮肤转移, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8672e321901f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1351118, encodeId=907013511185e, content=<a href='/topic/show?id=12e43e1263' target=_blank style='color:#2F92EE;'>#Breast#</a>, objectTitle=NEJM：新型HER2-ADC Enhertu打破HER2低表达的乳腺癌治疗困境（DESTINY-Breast04）, objectType=article, longId=728825, objectId=0933e28825b2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0933e28825b2, replyNumber=0, likeNumber=71, createdTime=2022-06-09, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0933e28825b2, moduleTitle=NEJM：新型HER2-ADC Enhertu打破HER2低表达的乳腺癌治疗困境（DESTINY-Breast04）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0933e28825b2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1351119, encodeId=77051351119cf, content=<a href='/topic/show?id=12e43e1263' target=_blank style='color:#2F92EE;'>#Breast#</a>, objectTitle=ASCO2022 | 里程碑式突破！DESTINYBreast04结果显示，T-DXd对HER2-低表达mBC安全有效！, objectType=article, longId=728766, objectId=ebf0e2876637, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ebf0e2876637, replyNumber=0, likeNumber=83, createdTime=2022-06-08, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ebf0e2876637, moduleTitle=ASCO2022 | 里程碑式突破！DESTINYBreast04结果显示，T-DXd对HER2-低表达mBC安全有效！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ebf0e2876637)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1351120, encodeId=6cb81351120f6, content=<a href='/topic/show?id=12e43e1263' target=_blank style='color:#2F92EE;'>#Breast#</a>, objectTitle=Breast Cancer Res Treat：乳房游离皮瓣患者围手术期使用他莫昔芬并不会增加并发症的发生风险, objectType=article, longId=728187, objectId=71f1e281872b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=71f1e281872b, replyNumber=0, likeNumber=92, createdTime=2022-05-31, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=71f1e281872b, moduleTitle=Breast Cancer Res Treat：乳房游离皮瓣患者围手术期使用他莫昔芬并不会增加并发症的发生风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=71f1e281872b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1351117, encodeId=8515135111ee3, content=<a href='/topic/show?id=12e43e1263' target=_blank style='color:#2F92EE;'>#Breast#</a>, objectTitle=期刊推荐：npj Breast Cancer, objectType=article, longId=295758, objectId=97a6295e5884, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=97a6295e5884, replyNumber=0, likeNumber=61, createdTime=2022-02-17, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=97a6295e5884, moduleTitle=期刊推荐：npj Breast Cancer, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=97a6295e5884)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1351116, encodeId=11a2135111639, content=<a href='/topic/show?id=12e43e1263' target=_blank style='color:#2F92EE;'>#Breast#</a>, objectTitle=BREAST CANCER RES TR：低风险早期乳腺癌，术后能不化疗吗？, objectType=article, longId=218783, objectId=b4df218e839b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b4df218e839b, replyNumber=0, likeNumber=99, createdTime=2021-10-19, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b4df218e839b, moduleTitle=BREAST CANCER RES TR：低风险早期乳腺癌，术后能不化疗吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b4df218e839b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1351115, encodeId=8419135111542, content=<a href='/topic/show?id=12e43e1263' target=_blank style='color:#2F92EE;'>#Breast#</a>, objectTitle=Breast Cancer Res：如何预测乳腺癌幸存者冠心病风险？看多基因风险评分啊！, objectType=article, longId=218197, objectId=16a921819eca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=16a921819eca, replyNumber=0, likeNumber=0, createdTime=2021-10-08, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=16a921819eca, moduleTitle=Breast Cancer Res：如何预测乳腺癌幸存者冠心病风险？看多基因风险评分啊！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=16a921819eca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1351114, encodeId=e77c1351114e2, content=<a href='/topic/show?id=12e43e1263' target=_blank style='color:#2F92EE;'>#Breast#</a>, objectTitle=Breast Cancer Res ：阿贝西利（Abemaciclib）联合氟维司群治疗绝经前女性HR+/HER2-的晚期乳腺癌疗效:来自MONARCH 2试验的亚组分析, objectType=article, longId=218041, objectId=1ce121804150, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1ce121804150, replyNumber=0, likeNumber=107, createdTime=2021-10-03, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1ce121804150, moduleTitle=Breast Cancer Res ：阿贝西利（Abemaciclib）联合氟维司群治疗绝经前女性HR+/HER2-的晚期乳腺癌疗效:来自MONARCH 2试验的亚组分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1ce121804150)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1351113, encodeId=89c11351113a3, content=<a href='/topic/show?id=12e43e1263' target=_blank style='color:#2F92EE;'>#Breast#</a>, objectTitle=BREAST CANCER RES TR：亚洲数据出炉！奈拉替尼对晚期乳腺癌疗效如何？, objectType=article, longId=217984, objectId=f7a521e984ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f7a521e984ef, replyNumber=0, likeNumber=92, createdTime=2021-10-02, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f7a521e984ef, moduleTitle=BREAST CANCER RES TR：亚洲数据出炉！奈拉替尼对晚期乳腺癌疗效如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f7a521e984ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1351112, encodeId=cce11351112b4, content=<a href='/topic/show?id=12e43e1263' target=_blank style='color:#2F92EE;'>#Breast#</a>, objectTitle=Breast：HER2低表达对激素受体阳性早期乳腺癌预后的影响, objectType=article, longId=217172, objectId=1d3d21e17209, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1d3d21e17209, replyNumber=0, likeNumber=147, createdTime=2021-09-17, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1d3d21e17209, moduleTitle=Breast：HER2低表达对激素受体阳性早期乳腺癌预后的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1d3d21e17209)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1351111, encodeId=358e13511117d, content=<a href='/topic/show?id=12e43e1263' target=_blank style='color:#2F92EE;'>#Breast#</a>, objectTitle=npj Breast Cancer：AI通过胶原蛋白排序情况，预测乳腺癌治疗后是否会复发, objectType=article, longId=215513, objectId=df6b215513e0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=df6b215513e0, replyNumber=0, likeNumber=93, createdTime=2021-08-11, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=df6b215513e0, moduleTitle=npj Breast Cancer：AI通过胶原蛋白排序情况，预测乳腺癌治疗后是否会复发, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=df6b215513e0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1351110, encodeId=a84b1351110c3, content=<a href='/topic/show?id=12e43e1263' target=_blank style='color:#2F92EE;'>#Breast#</a>, objectTitle=Breast：奥氮平可有效预防中国乳腺癌患者化疗所致恶心呕吐, objectType=article, longId=207745, objectId=30be20e745e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=30be20e745e6, replyNumber=0, likeNumber=151, createdTime=2021-03-01, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=30be20e745e6, moduleTitle=Breast：奥氮平可有效预防中国乳腺癌患者化疗所致恶心呕吐, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=30be20e745e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1351109, encodeId=b5cd135110972, content=<a href='/topic/show?id=12e43e1263' target=_blank style='color:#2F92EE;'>#Breast#</a>, objectTitle=Breast Cancer Res Treat：Palbociclib加来曲唑作为雌激素受体阳性/人表皮生长因子受体2阴性晚期乳腺癌的一线治疗效果, objectType=article, longId=195894, objectId=347c195894a4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=347c195894a4, replyNumber=0, likeNumber=107, createdTime=2020-06-16, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=347c195894a4, moduleTitle=Breast Cancer Res Treat：Palbociclib加来曲唑作为雌激素受体阳性/人表皮生长因子受体2阴性晚期乳腺癌的一线治疗效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=347c195894a4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1351108, encodeId=18f1135110873, content=<a href='/topic/show?id=12e43e1263' target=_blank style='color:#2F92EE;'>#Breast#</a>, objectTitle=Breast Cancer Res：确诊乳腺癌后适度增加运动或能降低死亡风险, objectType=article, longId=182605, objectId=d34e182605c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d34e182605c5, replyNumber=0, likeNumber=126, createdTime=2019-11-09, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d34e182605c5, moduleTitle=Breast Cancer Res：确诊乳腺癌后适度增加运动或能降低死亡风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d34e182605c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1351107, encodeId=d5c2135110e8f, content=<a href='/topic/show?id=12e43e1263' target=_blank style='color:#2F92EE;'>#Breast#</a>, objectTitle=npj Breast Cancer：超越人眼极限！AI识别出五种乳腺癌新亚型, objectType=article, longId=177229, objectId=ff9b1e7229f0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ff9b1e7229f0, replyNumber=0, likeNumber=110, createdTime=2019-08-10, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ff9b1e7229f0, moduleTitle=npj Breast Cancer：超越人眼极限！AI识别出五种乳腺癌新亚型, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ff9b1e7229f0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1351106, encodeId=a7421351106a4, content=<a href='/topic/show?id=12e43e1263' target=_blank style='color:#2F92EE;'>#Breast#</a>, objectTitle=ESMO Breast：间歇性治疗降低晚期乳腺癌患者的治疗效果, objectType=article, longId=165497, objectId=74b916549e94, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=74b916549e94, replyNumber=0, likeNumber=131, createdTime=2019-05-08, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=74b916549e94, moduleTitle=ESMO Breast：间歇性治疗降低晚期乳腺癌患者的治疗效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=74b916549e94)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1351105, encodeId=d6871351105f4, content=<a href='/topic/show?id=12e43e1263' target=_blank style='color:#2F92EE;'>#Breast#</a>, objectTitle=ESMO Breast：三阴性乳腺癌患者的肿瘤浸润淋巴细胞水平与PD-1单抗keytruda应答率呈显著正相关, objectType=article, longId=165486, objectId=e8fc16548616, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e8fc16548616, replyNumber=0, likeNumber=72, createdTime=2019-05-08, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e8fc16548616, moduleTitle=ESMO Breast：三阴性乳腺癌患者的肿瘤浸润淋巴细胞水平与PD-1单抗keytruda应答率呈显著正相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e8fc16548616)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1351104, encodeId=35c213511042c, content=<a href='/topic/show?id=12e43e1263' target=_blank style='color:#2F92EE;'>#Breast#</a>, objectTitle=Breast Cancer Res Treat：三阴性乳腺癌突变与复发率无关, objectType=article, longId=133975, objectId=2d4a1339e5a2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2d4a1339e5a2, replyNumber=0, likeNumber=92, createdTime=2018-04-03, rootId=0, userName=智慧医人, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2d4a1339e5a2, moduleTitle=Breast Cancer Res Treat：三阴性乳腺癌突变与复发率无关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2d4a1339e5a2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1351103, encodeId=f51913511035c, content=<a href='/topic/show?id=12e43e1263' target=_blank style='color:#2F92EE;'>#Breast#</a>, objectTitle=npj Breast Cancer：中国城市高危女性的乳腺癌风险因素和乳房密度|, objectType=article, longId=133570, objectId=3cf71335e0e0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3cf71335e0e0, replyNumber=0, likeNumber=91, createdTime=2018-03-28, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3cf71335e0e0, moduleTitle=npj Breast Cancer：中国城市高危女性的乳腺癌风险因素和乳房密度|, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3cf71335e0e0)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

Breast

2020-05-29

zhaojie88 (审核中...)

前往app查看评论内容

#Breast#

ESMO 2022：T-DXd治疗乳腺癌不仅能提高生存，还能改善生活质量（DESTINY-Breast04研究）

2022-09-13

zhaojie88 (审核中...)

前往app查看评论内容

#Breast#

Breast Cancer Res Treat：局部亚微米颗粒紫杉醇可有效治疗乳腺癌皮肤转移

2022-07-13

zhaojie88 (审核中...)

前往app查看评论内容

#Breast#

NEJM：新型HER2-ADC Enhertu打破HER2低表达的乳腺癌治疗困境（DESTINY-Breast04）

2022-06-09

zhaojie88 (审核中...)

前往app查看评论内容

#Breast#

ASCO2022 | 里程碑式突破！DESTINYBreast04结果显示，T-DXd对HER2-低表达mBC安全有效！

2022-06-08

zhaojie88 (审核中...)

前往app查看评论内容

#Breast#

Breast Cancer Res Treat：乳房游离皮瓣患者围手术期使用他莫昔芬并不会增加并发症的发生风险

2022-05-31

zhaojie88 (审核中...)

前往app查看评论内容

#Breast#

期刊推荐：npj Breast Cancer

2022-02-17

zhaojie88 (审核中...)

前往app查看评论内容

#Breast#

BREAST CANCER RES TR：低风险早期乳腺癌，术后能不化疗吗？

2021-10-19

zhaojie88 (审核中...)

前往app查看评论内容

#Breast#

Breast Cancer Res：如何预测乳腺癌幸存者冠心病风险？看多基因风险评分啊！

2021-10-08

zhaojie88 (审核中...)

前往app查看评论内容

#Breast#

Breast Cancer Res ：阿贝西利（Abemaciclib）联合氟维司群治疗绝经前女性HR+/HER2-的晚期乳腺癌疗效:来自MONARCH 2试验的亚组分析

2021-10-03

zhaojie88 (审核中...)

前往app查看评论内容

#Breast#

BREAST CANCER RES TR：亚洲数据出炉！奈拉替尼对晚期乳腺癌疗效如何？

2021-10-02

zhaojie88 (审核中...)

前往app查看评论内容

#Breast#

Breast：HER2低表达对激素受体阳性早期乳腺癌预后的影响

2021-09-17

zhaojie88 (审核中...)

前往app查看评论内容

#Breast#

npj Breast Cancer：AI通过胶原蛋白排序情况，预测乳腺癌治疗后是否会复发

2021-08-11

zhaojie88 (审核中...)

前往app查看评论内容

#Breast#

Breast：奥氮平可有效预防中国乳腺癌患者化疗所致恶心呕吐

2021-03-01

zhaojie88 (审核中...)

前往app查看评论内容

#Breast#

Breast Cancer Res Treat：Palbociclib加来曲唑作为雌激素受体阳性/人表皮生长因子受体2阴性晚期乳腺癌的一线治疗效果

2020-06-16

zhaojie88 (审核中...)

前往app查看评论内容

#Breast#

Breast Cancer Res：确诊乳腺癌后适度增加运动或能降低死亡风险

2019-11-09

zhaojie88 (审核中...)

前往app查看评论内容

#Breast#

npj Breast Cancer：超越人眼极限！AI识别出五种乳腺癌新亚型

2019-08-10

zhaojie88 (审核中...)

前往app查看评论内容

#Breast#

ESMO Breast：间歇性治疗降低晚期乳腺癌患者的治疗效果

2019-05-08

zhaojie88 (审核中...)

前往app查看评论内容

#Breast#

ESMO Breast：三阴性乳腺癌患者的肿瘤浸润淋巴细胞水平与PD-1单抗keytruda应答率呈显著正相关

2019-05-08

智慧医人 (审核中...)

前往app查看评论内容

#Breast#

Breast Cancer Res Treat：三阴性乳腺癌突变与复发率无关

2018-04-03

zhaojie88 (审核中...)

前往app查看评论内容

#Breast#

npj Breast Cancer：中国城市高危女性的乳腺癌风险因素和乳房密度|

2018-03-28

科室
- - 订阅+
  - 更多科室
工具
服务